Inogen INC
-$9.2M
Net Activity
Institutions Holding
125
Popularity Rank
#3978
Avg Weight
0.03%
Total Value
$116.5M
125 institutions currently hold INGN, with 61 net buyers and 71 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
71
Net Buying Institutions
61
Top 5 by Value
+$44.8M
Total Buy Value
$75.9M
Total Sell Value
61
Net Buyers
71
Net Sellers
1
Filings (90d)
$71K
Total Est. Value
11K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| JENNIFER YI BOYER | 2026-07-01 | $71K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
1
Filings (14d)
Inogen appointed Andy Reding as its new Chief Operating Officer, effective July 6, 2026. Reding brings experience from Viant Medical and Hillrom. His compensation package includes a $500,000 base salary, a target annual bonus of 70% of salary, a $100,000 sign-on bonus, and 130,000 restricted stock units vesting over three years. The appointment strengthens Inogen's operational leadership.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter